It is the most effective oral skin lightener available and has numerous other health benefits
(2) Patients with major heart, liver, kidney, and other organ disorders, including co-infection with hepatitis C virus (HCV), hepatitis D virus (HDV), or other chronic liver diseases such as alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), and autoimmune hepatitis
Incretins (GLP1 r agonists and dual, triple agonists) and the liver
Wegovy (semaglutide) and Mounjaro (tirzepatide) are part of a class of medications known as GLP-1 receptor agonists
Considerations that typically inform the decision include: Primary goal: weight management, glycemic control, or both Tolerability: how each medication's side effects affect you personally Medical history: contraindications, comorbidities, and concurrent medications Cardiovascular data: semaglutide has longer-established outcome evidence Access and cost: insurance coverage, pricing, and local supply Formulation preference: injection versus, for semaglutide, an oral diabetes option A practical way to think about it: tirzepatide's dual mechanism gives it an edge in average efficacy, while semaglutide offers a longer real-world track record and additional formulation flexibility
One of the five peptides was removed from Category 2 in September 2024 and referred to PCAC